الإحصائيات الأساسية
| LEI | 549300LC82HG33S19I03 |
| CIK | 1638833 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Surgery Partners, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 13, 2025 |
SECOND AMENDMENT TO CREDIT AGREEMENT Exhibit 10.1 SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) dated as of August 13, 2025 is among SP HOLDCO I, INC., a Delaware corporation (“Holdings”), SURGERY CENTER HOLDINGS, INC., a Delaware corporation (the “Borrower”), the subsidiaries of the Borrower listed on the signature pages hereto (the “Subsidiary Guarantors”), the lenders liste |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regist |
|
| August 5, 2025 |
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2025 RESULTS REAFFIRMS FULL YEAR 2025 GUIDANCE Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2025 RESULTS REAFFIRMS FULL YEAR 2025 GUIDANCE BRENTWOOD, Tenn., August 5, 2025 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlig |
|
| June 17, 2025 |
Exhibit 99.1 SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions - Board reaffirms its confidence in the Company’s long-term growth prospects; Company reiterates full-year 2025 financial guidance Company expects to host an Investor Day in the second half of 2025 to discuss its future growth plans and long-term outlook - BRENTWOOD, Tenn., June 17, 2025 (GLOBE NEWSWIRE) - Surgery Partners, |
|
| June 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| June 10, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Surgery Partners, Inc. |
|
| June 10, 2025 |
As filed with the Securities and Exchange Commission on June 10, 2025 As filed with the Securities and Exchange Commission on June 10, 2025 Registration No. |
|
| June 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regis |
|
| May 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 12, 2025 |
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2025 RESULTS REAFFIRMS FULL YEAR 2025 GUIDANCE Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2025 RESULTS REAFFIRMS FULL YEAR 2025 GUIDANCE BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| March 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of registrant as specifi |
|
| March 7, 2025 |
List of Subsidiaries of the Registrant. Exhibit 21.1 Subsidiaries of Surgery Partners, Inc. Entity Name Jurisdiction of Organization Doing Business As Advanced Surgery Center, LLC Nebraska A&S Management, LLC Delaware Afshin Gerayli, M.D., A Professional Corporation California Pain Specialists of Orange County Alaska Digestive Center, LLC Alaska AllCare Holdco PC North Carolina Ambulatory Resource Centres Investment Company, LLC Delawar |
|
| March 7, 2025 |
Exhibit 19 Final Form Amended and Restated Insider Trading Policy of Surgery Partners, Inc. |
|
| March 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number: 001-37576 CUSIP Number: 86881A100 NOTIFICATION OF LATE FILING (Check One) ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr |
|
| March 3, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| March 3, 2025 |
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS; SETS 2025 GUIDANCE Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS; SETS 2025 GUIDANCE BRENTWOOD, Tenn., March 3, 2025 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and F |
|
| February 10, 2025 |
EX-99 2 Rule13DJointFilingAgreement.htm JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Surgery Partners, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) |
|
| January 28, 2025 |
Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital Exhibit 99.1 Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital BRENTWOOD, Tenn., January 28, 2025 – Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced that its Board of Directors (the “Board”) received a non-binding proposal, dated January 27, 2025, from |
|
| January 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| January 13, 2025 |
SURGERY PARTNERS, INC. NAMES LAURA L. FORESE, MD TO BOARD OF DIRECTORS Exhibit 99.1 SURGERY PARTNERS, INC. NAMES LAURA L. FORESE, MD TO BOARD OF DIRECTORS BRENTWOOD, Tenn., January 13, 2025 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese’s appointment, which is effective January 10, 2025, w |
|
| January 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2025 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 12, 2024 |
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2024 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2024 RESULTS BRENTWOOD, Tenn., November 12, 2024 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2024. •Revenues increased 14.3% to $770.4 million compared to the prior |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of r |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| November 8, 2024 |
EX-99 2 Rule13DJointFilingAgreement.htm JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Surgery Partners, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) |
|
| November 8, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Surgery Partners, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 86881A100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| August 23, 2024 |
etter from Deloitte & Touche LLP, dated A August 21, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Dear Ladies and Gentlemen, We have read Item 4.01 of Surgery Partners, Inc.’s Form 8-K dated August 21, 2024, and agree with the statements made therein. Yours truly, /s/ Deloitte & Touche LLP |
|
| August 23, 2024 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 6, 2024 |
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2024 RESULTS RAISES FULL YEAR 2024 GUIDANCE EX-99.1 2 exhibit991q22024earningsre.htm EX-99.1 Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2024 RESULTS RAISES FULL YEAR 2024 GUIDANCE BRENTWOOD, Tenn., August 6, 2024 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 3 |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 6, 2024 |
etirement Agreement, dated August 5, 2024, by and b Exhibit 10.3 RETIREMENT AGREEMENT This RETIREMENT AGREEMENT (the “Agreement”) is entered into on August 5, 2024, by and between Surgery Partners, Inc., a Delaware corporation (the “Company”), and Brad Owens, a resident of Tennessee (“Executive”). WHEREAS, Executive is employed by and provides services to the Company as the President of the National Group; WHEREAS, Executive has expressed a desire |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regist |
|
| August 6, 2024 |
erein by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K filed August 6, 2 SP Management Services, Inc. Effective August 1st, 2024 IMPORTANT NOTE This document has not been approved by the Department of Labor, Internal Revenue Service, or any other governmental entity. An adopting Employer must determine whether the Plan is subject to the Federal securities laws and the securities laws of the various states. An adopting Employer may not rely on this document to ensure an |
|
| June 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| June 20, 2024 |
Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) dated as of June 20, 2024 is among SP HOLDCO I, INC., a Delaware corporation (“Holdings”), SURGERY CENTER HOLDINGS, INC., a Delaware corporation (the “Borrower”), the subsidiaries of the Borrower listed on the signature pages hereto (the “Subsidiary Guarantors”), the lenders listed on the s |
|
| June 11, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 7, 2024 |
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2024 RESULTS RAISES FULL YEAR 2024 GUIDANCE Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2024 RESULTS RAISES FULL YEAR 2024 GUIDANCE BRENTWOOD, Tenn., May 7, 2024 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2024. •Revenues increased 7.7% to $717.4 million c |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regis |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 10, 2024 |
Exhibit 4.1 SURGERY CENTER HOLDINGS, INC., as Issuer the GUARANTORS party hereto from time to time and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee $800,000,000 7.250% Senior Notes due 2032 INDENTURE Dated as of April 10, 2024 TABLE OF CONTENTS Page Article I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 57 Section 1.3 Incorporation by R |
|
| April 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 26, 2024 |
SURGERY PARTNERS, INC. ANNOUNCES PRICING OF NEW SENIOR NOTES OFFERING Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES PRICING OF NEW SENIOR NOTES OFFERING BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $800,000,000 aggregate principal amount of its 7.250% senior unsecured notes due 2032 ( |
|
| March 26, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 26, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 26, 2024 |
SURGERY PARTNERS, INC. ANNOUNCES NEW SENIOR NOTES OFFERING Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES NEW SENIOR NOTES OFFERING BRENTWOOD, Tenn., March 26, 2024 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to mar |
|
| February 26, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| February 26, 2024 |
List of Subsidiaries of the Registrant. Exhibit 21.1 Subsidiaries of Surgery Partners, Inc. Entity Name Jurisdiction of Organization Doing Business As Advanced Pain Institute Treatment Center, LLC Louisiana Advanced Surgery Center, LLC Nebraska A&S Management, LLC Delaware Afshin Gerayli, MD California Pain Specialists of Orange County Alaska Digestive Center, LLC Alaska AllCare Holdco PC North Carolina Ambulatory Resource Centres Inves |
|
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of registrant as specifi |
|
| February 26, 2024 |
Surgery Partners, Inc. Executive Compensation Recovery Policy Exhibit 97 SURGERY PARTNERS, INC. EXECUTIVE COMPENSATION RECOVERY POLICY In accordance with the Rule 5608 of the Nasdaq Stock Market and Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Board of Directors of Surgery Partners, Inc., a Delaware corporation (the “Company”), has adopted this policy regarding the recovery of erroneously awarded Inc |
|
| February 26, 2024 |
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS; SETS 2024 GUIDANCE Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS; SETS 2024 GUIDANCE BRENTWOOD, Tenn., February 26, 2024 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2023. •Revenue increas |
|
| February 13, 2024 |
SGRY / Surgery Partners, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv02021-surgerypartnersinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Surgery Partners Inc Title of Class of Securities: Common Stock CUSIP Number: 86881A100 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to desi |
|
| February 8, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Surgery Partners, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 86881A100 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| January 8, 2024 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| December 21, 2023 |
SGRY / Surgery Partners, Inc. / BCPE Seminole Holdings LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240. |
|
| December 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| December 20, 2023 |
Exhibit 10.1 Execution Version CREDIT AGREEMENT Dated as of December 19, 2023 by and among SP HOLDCO I, INC., as Holdings, SURGERY CENTER HOLDINGS, INC., as the Borrower, the several Lenders and Letter of Credit Issuers from time to time parties hereto, JEFFERIES FINANCE LLC, as the Administrative Agent and the Collateral Agent, and Jefferies Finance LLC, Barclays Bank PLC, |
|
| December 18, 2023 |
Exhibit 1.1 Surgery Partners, Inc. 8,000,000 Shares of Common Stock Underwriting Agreement December 14, 2023 Jefferies LLC 520 Madison Avenue New York, New York 10022 Ladies and Gentlemen: Certain stockholders named in Schedule 1 hereto (the “Selling Stockholders”) of Surgery Partners, Inc., a Delaware corporation (the “Company”), propose to sell to Jefferies LLC (the “Underwriter”) an aggregate o |
|
| December 18, 2023 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-3 ASR (Form Type) Surgery Partners, Inc. |
|
| December 18, 2023 |
TABLE OF CONTENTS Filed pursuant to Rule 424(b)(7) Registration No. 333-252399 P R O S P E C T U S S U P P L E M E N T (To Prospectus dated January 25, 2021) 8,000,000 Shares Common stock The selling stockholders listed in this prospectus supplement are offering 8,000,000 shares of our common stock. We will not receive any proceeds from the sale of our common stock by the selling stockholders. |
|
| December 18, 2023 |
Information Relating to Part II. Exhibit 99.1 Information Relating to Part II. Item 14. - Other Expenses of Issuance and Distribution The expenses in connection with the offer and sale of common stock of Surgery Partners, Inc., registered pursuant to the Registration Statement on Form S-3ASR (Registration No. 333-252399) filed on January 25, 2021, other than underwriting discounts and commissions, are set forth in the following t |
|
| December 18, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| December 14, 2023 |
Subject to completion, dated December 14, 2023 TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| December 14, 2023 |
SURGERY PARTNERS, INC. ANNOUNCES PROPOSED SECONDARY OFFERING OF COMMON STOCK Filed Pursuant to Rule 433 Registration Statement No. 333-252399 SURGERY PARTNERS, INC. ANNOUNCES PROPOSED SECONDARY OFFERING OF COMMON STOCK BRENTWOOD, Tenn., December 14, 2023 (GLOBE NEWSWIRE) Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners” or the “Company”) today announced that certain of the Company’s stockholders (the “Selling Stockholders”) intend to offer for sale in an underwritt |
|
| December 6, 2023 |
SURGERY PARTNERS, INC. COMPLETES REFINANCING TRANSACTION Exhibit 99.1 SURGERY PARTNERS, INC. COMPLETES REFINANCING TRANSACTION BRENTWOOD, Tenn., December 6, 2023 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company, has received commitments for a new $1.4 billion |
|
| December 6, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 7, 2023 |
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS BRENTWOOD, Tenn., November 7, 2023 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023. •Revenues were $674.1 million representing 8.6% growth •Days Adjusted Sa |
|
| November 7, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of r |
|
| August 1, 2023 |
surgerypartners-tenthame /s/ Peter Cucchiara CREDIT AGREEMENT dated as of August 31, 2017 among SP HOLDCO I, INC. |
|
| August 1, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 1, 2023 |
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2023 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2023 RESULTS BRENTWOOD, Tenn., August 1, 2023 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the second quarter ended June 30, 2023. •Revenues were $667.6 million representing 8.5% growth and are inclusive of an |
|
| August 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regist |
|
| June 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regis |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 1, 2023 |
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2023 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2023 RESULTS BRENTWOOD, Tenn., May 1, 2023 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced financial results for the first quarter ended March 31, 2023. •Revenue increased 11.7% from the prior year period to $666.2 million ◦Same-facilit |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| March 3, 2023 |
SGRY / Surgery Partners Inc / BCPE Seminole Holdings LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240. |
|
| March 1, 2023 |
Employment Agreement, dated July 25, 2022, by and between Surgery Partners, Inc. and Harrison Bane. Exhibit 10.41 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "Agreement") is hereby entered into effective as of July 25, 2022 (the "Effective Date"), between Surgery Partners, Inc. (the "Company") and Harrison Bane ("Executive"). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set forth in th |
|
| March 1, 2023 |
List of Subsidiaries of the Registrant. Exhibit 21.1 Subsidiaries of Surgery Partners, Inc. Entity Name Jurisdiction of Organization Doing Business As Advanced Pain Institute Treatment Center, LLC Louisiana Advanced Surgery Center, LLC Nebraska A&S Management, LLC Delaware Afshin Gerayli, MD California Pain Specialists of Orange County AllCare Holdco PC North Carolina Ambulatory Resource Centres Investment Company, LLC Delaware Ambulato |
|
| March 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of registrant as specifi |
|
| March 1, 2023 |
Exhibit 10.15 Execution Version NINTH AMENDMENT TO CREDIT AGREEMENT This NINTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of January 13, 2023, by and among Surgery Center Holdings, Inc., a Delaware corporation (the “Borrower”), SP Holdco I, Inc., a Delaware corporation (“Holdings”), the other Guarantors party hereto, each 2023 Incremental Revolving Lender (as defined below) party h |
|
| March 1, 2023 |
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS; SETS 2023 GUIDANCE Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS; SETS 2023 GUIDANCE BRENTWOOD, Tenn., March 1, 2023 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fourth quarter and full year ended December 31, 2022. •Revenue increased 15.9% to $707.1 mil |
|
| March 1, 2023 |
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Surgery Partners, Inc. (referred to in this exhibit as “we,” “us,” “our” or the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, $0.01 par value per share. All references to “common st |
|
| March 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| February 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Surgery Partners, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 86881A100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 9, 2023 |
SGRY / Surgery Partners Inc / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SC 13G 1 tv01992-surgerypartnersinc.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Surgery Partners Inc. Title of Class of Securities: Common Stock CUSIP Number: 86881A100 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant |
|
| February 6, 2023 |
SGRY / Surgery Partners Inc / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Surgery Partners, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 86881A100 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S |
|
| January 9, 2023 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2023 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| December 27, 2022 |
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13D EX-99.9 Exhibit 9 AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13D The undersigned being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, as amended, to file this Schedule 13D (including amendments thereto) joi |
|
| December 27, 2022 |
SGRY / Surgery Partners Inc / BCPE Seminole Holdings LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240. |
|
| December 22, 2022 |
Exhibit 10.1 AMENDMENT AND JOINDER TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDMENT AND JOINDER TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this ?Amendment?), effective as of December 22, 2022 is made by and among Surgery Partners, Inc., a Delaware corporation (the ?Company?), BCPE Seminole Holdings LP, a Delaware limited partnership (?Bain?), BCPE Seminole Holdings |
|
| December 22, 2022 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2022 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| December 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Surgery Partners, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 86881A100 (CUSIP Number) November 23, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| November 23, 2022 |
EX-7 Exhibit 7 FORM OF LOCK-UP AGREEMENT [ ], 2022 BOFA SECURITIES, INC. J.P. MORGAN SECURITIES LLC BARCLAYS CAPITAL INC. JEFFERIES LLC As Representatives of the several Underwriters listed in Schedule 1 to the Underwriting Agreement referred to below Re: Surgery Partners, Inc. — Public Offering Ladies and Gentlemen: The undersigned understands that you, as Representatives of the several Underwrit |
|
| November 23, 2022 |
SGRY / Surgery Partners Inc / BCPE Seminole Holdings LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240. |
|
| November 22, 2022 |
EX-FILING FEES 2 tm2230583d3ex-filingfees.htm EX-FILING FEES EX-FILING FEES Calculation of Filing Fee Table Form 424(b)(5) (Form Type) Surgery Partners, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit |
|
| November 22, 2022 |
Exhibit 10.1 EXECUTION VERSION STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (“Agreement”) is entered into as of November 21, 2022 (the “Execution Date”), by and between Surgery Partners, Inc., a Delaware corporation (“Surgery”), and Bain Capital Fund XI, L.P., a Cayman Islands limited partnership (“Bain Capital”). Surgery and Bain Capital may individually be referred to as a “Party” and |
|
| November 22, 2022 |
EX-1.1 2 tm2230583d4ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 Execution Version Surgery Partners, Inc. 23,469,388 Shares of Common Stock Underwriting Agreement November 21, 2022 BofA Securities, Inc. J.P. Morgan Securities LLC Barclays Capital Inc. Jefferies LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o BofA Securities, Inc. One Bryant Park New York, New York 10036 c/o |
|
| November 22, 2022 |
23,469,388 Shares Common stock TABLE OF CONTENTS ?Filed pursuant to Rule 424(b)(5) ?Registration No. 333-252399? P R O S P E C T U S??S U P P L E M E N T (To Prospectus dated January 25, 2021) 23,469,388 Shares Common stock We are offering 23,469,388 shares of our common stock. Our common stock is listed on the Nasdaq Global Select Market under the symbol ?SGRY.? On November 18, 2022, the last reported sale price for our common |
|
| November 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2022 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| November 21, 2022 |
Subject to completion, dated November 21, 2022 TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| November 8, 2022 |
Execution Version Exhibit 10.1 EIGHTH AMENDMENT TO CREDIT AGREEMENT This EIGHTH AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?), dated as of August 18, 2022, by and among Surgery Center Holdings, Inc., a Delaware corporation (the ?Borrower?), SP Holdco I, Inc., a Delaware corporation (?Holdings?), the other Guarantors party hereto, each 2022 Incremental Revolving Lender (as defined below) party h |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of r |
|
| November 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 8, 2022 |
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2022 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2022 RESULTS BRENTWOOD, Tenn., November 8, 2022 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the third quarter ended September 30, 2022. ?Revenue increased 11.0% from the prior year period to $620.6 million with same-faci |
|
| August 2, 2022 |
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2022 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2022 RESULTS ?Revenue increased 13.3% from the prior year period to $615.4 million ?Days adjusted same-facility revenues increased 6.9% from the prior year period ?Net loss attributable to common stockholders was $18.4 million ?Adjusted EBITDA increased 13.4% over the prior year period to $86.1 million, inclusive of a $0.1 million benefi |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regist |
|
| August 2, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2022 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| May 20, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2022 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 3, 2022 |
Exhibit 10.3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into effective as of March 8, 2022 (the ?Effective Date?), between Surgery Partners, Inc. (the ?Company?) and Bradley Owens (?Executive?). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon |
|
| May 3, 2022 |
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2022 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2022 RESULTS ?Revenues increased 16.4% to $596.2 million, when compared to the prior year period ?Days adjusted same-facility revenues increased 8.2% from the prior year period ?Days adjusted same-facility case volume increased 6.3% from the prior year period ?Net income attributable to common stockholders was $12.2 million ?Adjusted EBIT |
|
| May 3, 2022 |
Exhibit 10.2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into effective as of March 8, 2022 (the ?Effective Date?), between Surgery Partners, Inc. (the ?Company?) and Anthony W. Taparo (?Executive?). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, |
|
| May 3, 2022 |
Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into effective as of March 11, 2022 (the ?Effective Date?), between Surgery Partners, Inc. (the ?Company?) and Jennifer Baldock (?Executive?). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, |
|
| May 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regis |
|
| April 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| March 1, 2022 |
Exhibit 10.40 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into effective as of November 23, 2021 (the ?Effective Date?), between Surgery Partners, Inc. (the ?Company?) and Marissa Brittenham (?Executive?). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set fo |
|
| March 1, 2022 |
Exhibit 10.41 RETIREMENT AND CONSULTING AGREEMENT This RETIREMENT AND CONSULTING AGREEMENT (the ?Agreement?) is entered into on February 25, 2022, by and between Surgery Partners, Inc., a Delaware corporation (the ?Company?), and George M. Goodwin, a resident of Tennessee (?Executive?). WHEREAS, Executive is employed by and provides services to the Company as the President of the American Group; W |
|
| March 1, 2022 |
List of Subsidiaries of the Registrant. Exhibit 21.1 Subsidiaries of Surgery Partners, Inc. Entity Name Jurisdiction of Organization Doing Business As Advanced Pain Institute Treatment Center, LLC Louisiana Advanced Surgery Center, LLC Nebraska A&S Management, LLC Delaware Afshin Gerayli, MD California Pain Specialists of Orange County AllCare Holdco PC North Carolina Ambulatory Resource Centres Investment Company, LLC Delaware Ambulato |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of registrant as specifi |
|
| February 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2022 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| February 28, 2022 |
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS; RAISES 2022 GUIDANCE Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS; RAISES 2022 GUIDANCE ?Net loss attributable to common stockholders was $0.1 million for the fourth quarter 2021; $81.2 million for the full-year 2021 ?Fourth quarter 2021 Adjusted EBITDA increased 26.0% over the prior year period to $114.4 million, inclusive of an $11.6 million benefit from the recognition of |
|
| February 9, 2022 |
SGRY / Surgery Partners Inc / Clearbridge Investments, LLC Passive Investment CUSIP NO. 86881A100 13G Page 1 of 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Surgery Partners, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 86881A100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check th |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2022 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| January 10, 2022 |
Exhibit 99.1 SURGERY PARTNERS REAFFIRMS 2021 AND 2022 FULL YEAR GUIDANCE; DAVID T. DOHERTY TO ASSUME ROLE OF CHIEF FINANCIAL OFFICER ON FEBRUARY 1, 2022 BRENTWOOD, Tenn., January 10, 2022 (GLOBE NEWSWIRE) - Members of management of Surgery Partners, Inc. (NASDAQ: SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors t |
|
| January 10, 2022 |
Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into effective as of January 7, 2022 (the ?Effective Date?), between Surgery Partners, Inc. (the ?Company?) and David Doherty (?Executive?). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set forth in t |
|
| November 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| November 22, 2021 |
Exhibit 10.1 Execution Version SEVENTH AMENDMENT TO CREDIT AGREEMENT This SEVENTH AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?), dated as of November 19, 2021, by and among Surgery Center Holdings, Inc., a Delaware corporation (the ?Borrower?), SP Holdco I, Inc., a Delaware corporation (?Holdings?), the other Guarantors party hereto, each November 2021 Incremental Revolving Lender (as defined b |
|
| November 15, 2021 |
SGRY / Surgery Partners Inc / BCPE Seminole Holdings LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240. |
|
| November 10, 2021 |
Calculation of Registration Fee TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(5)? ?Registration No: 333-252399? Calculation of Registration Fee ? ? ? ? ? ? Amount to be Registered ? ? ? Proposed Maximum Offering Price Per Share ? ? ? Proposed Maximum Aggregate Offering Price(1) ? ? ? Amount of Registration Fee(2) ? Common Stock, $0. |
|
| November 9, 2021 |
Exhibit 1.1 ? EXECUTION VERSION ? Surgery Partners,?Inc. ? 6,000,000 Shares of Common Stock ? Underwriting Agreement ? November?8, 2021 ? BofA Securities,?Inc. J.P. Morgan Securities LLC Jefferies LLC As Representatives of the ?????several Underwriters listed ?????in Schedule 1 hereto ? c/o BofA Securities,?Inc. One Bryant Park New York, New York 10036 ? c/o J.P. Morgan Securities LLC 383 Madison |
|
| November 9, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 8, 2021 |
Subject to completion, dated November 8, 2021 TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| November 5, 2021 |
As filed with the Securities and Exchange Commission on November 5, 2021 As filed with the Securities and Exchange Commission on November 5, 2021 Registration No. |
|
| November 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of r |
|
| November 2, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 2, 2021 |
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2021 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2021 RESULTS BRENTWOOD, Tenn., November 2, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the third quarter ended September 30, 2021. ?Revenues increased 12.7% from the prior year period to $559.2 million ?Days adjuste |
|
| August 17, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 17, 2021 |
Investor Presentation – August 2021 Exhibit 99.1 Investor Presentation ? August 2021 ? 2021 Surgery Partners ? Confidential & Proprietary Information Legal Disclaimer 2 Forward - Looking Statements Statements contained in this presentation, other than statements of historical fact, are forward - looking statements . In some cases, you can identify forward - looking statements by terms such as ?may,? ?will,? ?should,? ?could,? ?would |
|
| August 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regist |
|
| August 4, 2021 |
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2021 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2021 RESULTS BRENTWOOD, Tenn., August 4, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter ended June 30, 2021. ?Revenues increased approximately 45% from the prior year period to $543.3 million ?Days |
|
| August 4, 2021 |
Exhibit 10.2 First Amendment to the Amended and Restated Surgery Partners, Inc. 2015 Omnibus Incentive Plan This Amendment to the Surgery Partners, Inc. 2015 Omnibus Incentive Plan, as amended and restated effective January 1, 2020 (the ?Plan?), is adopted by Surgery Partners, Inc. (the ?Company?), to be effective upon approval by the stockholders of the Company. RECITALS: WHEREAS, the Company has |
|
| May 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 19, 2021 |
SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240. |
|
| May 18, 2021 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 5, 2021 |
Exhibit 10.1 Execution Version SIXTH AMENDMENT TO CREDIT AGREEMENT This SIXTH AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?), dated as of May 3, 2021, by and among Surgery Center Holdings, Inc., a Delaware corporation (the ?Borrower?), SP Holdco I, Inc., a Delaware corporation (?Holdings?), the other Guarantors party hereto, Jefferies Finance LLC, as the 2021 Incremental Term Lender, the Extendi |
|
| May 5, 2021 |
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2021 RESULTS; COMPLETES REFINANCING TRANSACTIONS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2021 RESULTS; COMPLETES REFINANCING TRANSACTIONS BRENTWOOD, Tenn., May 5, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the first quarter ended March 31, 2021. ?Revenues increased 16.2% from the prior year period to $ |
|
| May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regis |
|
| April 20, 2021 |
Lender Presentation April 2021 Exhibit 99.1 Lender Presentation April 2021 2 Legal Disclaimer Forward - Looking Statements This presentation contains ?forward - looking? statements, including statements regarding the anticipated conversion of the Series A Preferred Stock, the Incremental Term Loan, including its anticipated amount and use of proceeds, and statements about the results anticipated to be reported by the Company fo |
|
| April 20, 2021 |
Exhibit 99.2 SURGERY PARTNERS, INC. ANNOUNCES TERM LOAN REFINANCING AND CONVERSION OF PREFERRED STOCK; PROVIDES PRELIMINARY FIRST QUARTER 2021 FINANCIAL PERFORMANCE UPDATE ? Refinancing $119 million of incremental term loans raised in April 2020 ? Provided notice to BCPE Seminole Holdings LP (?Bain Capital?) of its intention to convert Series A preferred stock into 22.609 million common shares ? F |
|
| April 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| March 10, 2021 |
Exhibit 10.35 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT THIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this ?Amendment?) is hereby entered into on August 7, 2019. by and between Surgery Partners. Inc. (?Parent?), Symbion, Inc. (?Symbion?, and together with Parent, the ?Company?) and Anthony W. Taparo (?Executive?). RECITALS A. The Company and the Executive entered into that certain Employment Agree |
|
| March 10, 2021 |
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 RESULTS BRENTWOOD, Tenn., March 10, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fourth quarter and full year ended December 31, 2020. Highlights for the Fourth Quarter 2020: •Revenues increas |
|
| March 10, 2021 |
List of Subsidiaries of the Registrant. Exhibit 21.1 Subsidiaries of Surgery Partners, Inc. Entity Name Jurisdiction of Organization Doing Business As Advanced Pain Institute Treatment Center, LLC Louisiana Advanced Surgery Center, LLC Nebraska A&S Management, LLC Delaware Afshin Gerayli, MD California Pain Specialists of Orange County AllCare Holdco PC North Carolina Ambulatory Resource Centres Investment Company, LLC Delaware Ambulato |
|
| March 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of registrant as specifi |
|
| March 10, 2021 |
Execution Version Exhibit 10.12 FIFTH AMENDMENT TO CREDIT AGREEMENT This FIFTH AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?), dated as of January 27, 2021, by and among Surgery Center Holdings, Inc., a Delaware corporation (the ?Borrower?), SP Holdco I, Inc., a Delaware corporation (?Holdings?), the other Guarantors party hereto, each 2021 New Revolving Lender (as defined below) party hereto, J |
|
| March 10, 2021 |
Employment Agreement, dated June 30, 2019, by and between Surgery Partners, Inc. and Laura Exhibit 10.37 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into effective as of June 30, 2019 (the ?Effective Date?), between Surgery Partners, Inc. (the ?Company?) and Laura Brocklehurst (?Executive?). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set forth |
|
| March 10, 2021 |
, 2019, by and between Surgery Partners, Inc. and Brad Exhibit 10.36 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into effective as of November 12, 2019 (the ?Effective Date?), between Surgery Partners, Inc. (the ?Company?) and Brad Owens (?Executive?). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set forth in t |
|
| March 10, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 2, 2021 |
SURGERY PARTNERS, INC. NAMES PATRICIA A. MARYLAND, DR TO BOARD OF DIRECTORS EX-99 2 a20210224-drmarylandappoin.htm EX-99 SURGERY PARTNERS, INC. NAMES PATRICIA A. MARYLAND, DR TO BOARD OF DIRECTORS BRENTWOOD, Tenn., March 1, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that Dr. Patricia A. Maryland has been appointed to serve as an independent director on its Boa |
|
| March 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| February 12, 2021 |
SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240. |
|
| February 11, 2021 |
CUSIP NO. 86881A100 13G Page 1 of 7 surg20a3.htm - Generated by SEC Publisher for SEC Filing CUSIP NO. 86881A100 13G Page 1 of 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Surgery Partners, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 86881A100 (CUSIP Number) December 31, 2020 (Date o |
|
| January 29, 2021 |
Exhibit 1.1 Execution Version Surgery Partners, Inc. 8,625,000 Shares of Common Stock Underwriting Agreement January 27, 2021 J.P. Morgan Securities LLC Jefferies LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Jefferies LLC 520 Madison Avenue New York, New York 10022 Ladies and Gentlemen: |
|
| January 29, 2021 |
TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No: 333-252399 Calculation of Registration Fee Amount to be Registered Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price(1) Amount of Registration Fee(2) Common Stock, $0. |
|
| January 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| January 26, 2021 |
TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| January 25, 2021 |
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 25, 2021 Registration Statement No. |
|
| January 11, 2021 |
Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2021 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 4, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 4, 2020 |
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2020 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2020 RESULTS BRENTWOOD, Tenn., November 4, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2020. •Revenues increased 9.8% from the prior year period to $496.1 mill |
|
| November 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of r |
|
| August 5, 2020 |
Exhibit 10.1 SURGERY PARTNERS, INC. CASH INCENTIVE PLAN 1. PURPOSE This Cash Incentive Plan (the “Plan”) has been established to advance the interests of Surgery Partners, Inc. (the “Company”) by providing for the grant of Cash Incentive Awards (as defined below) to eligible employees of the Company and its affiliates that are generally based on performance. The Plan was amended on March 18, 2020. |
|
| August 5, 2020 |
Exhibit 10.2 SURGERY PARTNERS, INC. 2015 OMNIBUS INCENTIVE PLAN Amended and Restated January 1, 2020 1. DEFINED TERMS Exhibit A, which is incorporated by reference, defines the terms used in the Plan and sets forth certain operational rules related to those terms. 2. PURPOSE The Plan has been established to advance the interests of the Company and its Affiliates by providing for the grant to Parti |
|
| August 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 5, 2020 |
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2020 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2020 RESULTS BRENTWOOD, Tenn., August 5, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2020. •Revenues decreased 15.9% from the prior year period to $374.7 million |
|
| August 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regist |
|
| July 31, 2020 |
Exhibit 4.1 SURGERY CENTER HOLDINGS, INC., as Issuer the GUARANTORS party hereto from time to time and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee SECOND SUPPLEMENTAL INDENTURE Dated as of July 30, 2020 10.000% Senior Notes due 2027 This SECOND SUPPLEMENTAL INDENTURE, dated as of July 30, 2020 (this “Supplemental Indenture”), is by and among Surgery Center Holdings, Inc., a Delaware corpora |
|
| July 31, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| July 31, 2020 |
Exhibit 4.1 SURGERY CENTER HOLDINGS, INC., as Issuer the GUARANTORS party hereto from time to time and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee SECOND SUPPLEMENTAL INDENTURE Dated as of July 30, 2020 10.000% Senior Notes due 2027 This SECOND SUPPLEMENTAL INDENTURE, dated as of July 30, 2020 (this “Supplemental Indenture”), is by and among Surgery Center Holdings, Inc., a Delaware corpora |
|
| July 31, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| July 24, 2020 |
Surgery Partners, Inc. Announces Pricing of Incremental Note Offering Exhibit 99.1 Surgery Partners, Inc. Announces Pricing of Incremental Note Offering Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $115.0 million aggregate principal amount of its 10.000% senior unsecured notes due 2027 (the “notes”) at 100.75% of the principal amount i |
|
| July 24, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| July 22, 2020 |
Investor Presentation, dated July 2020 Exhibit 99.1 SURGERY PARTNERS Lender Presentation July 2020 Exhibit 99.1 Legal Disclaimer Forward-Looking Statements This presentation contains forward-looking statements, which are based on our current expectations, estimates and assumptions about future events. All statements other than statements of current or historical fact contained in this report are forward-looking statements. These statem |
|
| July 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction (Commission File Number) (IRS Employ |
|
| May 28, 2020 |
Submission of Matters to a Vote of Security Holders 8-K 1 a20208-kannualmeetingresul.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdict |
|
| May 11, 2020 |
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2020 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2020 RESULTS BRENTWOOD, Tenn., May 11, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2020. • Revenues increased 5.8% over the prior year period to $441.0 million ◦ A |
|
| May 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regis |
|
| May 11, 2020 |
First Amendment to the Surgery Partners, Inc. Cash Incentive Plan. Exhibit 10.3 FIRST AMENDMENT TO THE SURGERY PARTNERS, INC. CASH INCENTIVE PLAN THIS AMENDMENT to the Surgery Partners, Inc. Cash Incentive Plan (the “Plan”) is made by Surgery Partners, Inc. (the “Company”) on this 18th day of March, 2020, but to be effective with respect to awards made beginning in 2019 and thereafter. RECITALS: WHEREAS, the Company established the Plan to provide incentive award |
|
| May 11, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 11, 2020 |
Exhibit 10.4 SETTLEMENT AGREEMENT This Settlement Agreement (Agreement) is entered into amongst the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS), the Defense Health Agency (DHA), acting on behalf of the TRICARE Program, the Office of Personnel Manageme |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 22, 2020 |
Exhibit 10.1 Execution Version THIRD AMENDMENT TO CREDIT AGREEMENT This THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of April 16, 2020, by and among Surgery Center Holdings, Inc., a Delaware corporation (the “Borrower”), SP Holdco I, Inc., a Delaware corporation (“Holdings”), the Revolving Lenders party hereto, Jefferies Finance LLC, as administrative agent for the Lenders (in |
|
| April 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 22, 2020 |
Exhibit 10.2 Execution Version SECOND INCREMENTAL TERM LOAN AMENDMENT This SECOND INCREMENTAL TERM LOAN AMENDMENT (this “Amendment”), dated as of April 22, 2020, by and among Surgery Center Holdings, Inc., a Delaware corporation (the “Borrower”), SP Holdco I, Inc., a Delaware corporation (“Holdings”), the other Guarantors party hereto, Jefferies Finance LLC, as the 2020 Incremental Term Lender, an |
|
| April 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 17, 2020 |
SGRY / Surgery Partners, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State |
|
| April 15, 2020 |
8-K 1 a202004158-kcovidsettlement.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisd |
|
| March 23, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 13, 2020 |
SGRY / Surgery Partners, Inc. 10-K - Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2019 OR o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of registrant as specifi |
|
| March 13, 2020 |
List of Subsidiaries of the Registrant. Exhibit 21.1 Subsidiaries of Surgery Partners, Inc. Entity Name Jurisdiction of Organization Doing Business As Advanced Pain Institute Treatment Center, LLC Louisiana Advanced Surgery Center, LLC Nebraska Afshin Gerayli, MD California Pain Specialists of Orange County AllCare Clinical Associates, P.A. North Carolina Ambulatory Resource Centres Investment Company, LLC Delaware Ambulatory Resource C |
|
| March 13, 2020 |
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Surgery Partners, Inc. (referred to in this exhibit as “we,” “us” or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, $0.01 par value per share. All references to “common stock” refer only |
|
| March 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| March 5, 2020 |
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 RESULTS BRENTWOOD, Tenn., March 5, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fourth quarter and full year ended December 31, 2019. Highlights for the Fourth Quarter 2019: • Revenues increas |
|
| February 14, 2020 |
SGRY / Surgery Partners, Inc. / Clearbridge Investments, LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* Surgery Partners, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 86881A100 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| January 13, 2020 |
Exhibit 10.1 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT This Amendment No. 1 (the “Amendment”) is effective as of January 13, 2020 (the “Effective Date”), and is by and between Surgery Partners, Inc. (“Parent”), Surgery Partners, LLC (“Partners” and, together with Parent, the “Company”), and Wayne DeVeydt (“you” or “Executive”). Capitalized terms not defined in this Amendment shall have the respectiv |
|
| January 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2020 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| January 13, 2020 |
Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES EXECUTIVE PROMOTIONS Wayne S. DeVeydt appointed to Executive Chairman of the Board Eric Evans appointed to Chief Executive Officer Company reaffirms 2019 full year guidance of double-digit Adjusted EBITDA growth BRENTWOOD, Tenn., January 13, 2020 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ: SGRY) ("Surgery Partners" or the "Company"), a leading s |
|
| January 13, 2020 |
Exhibit 10.2 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT This Amendment No. 1 (the “Amendment”) is effective as of January 13, 2020 (the “Effective Date”), and is by and between Surgery Partners, Inc. (“Parent”), Surgery Partners, LLC (“Partners” and, together with Parent, the “Company”), and J. Eric Evans (“you” or “Executive”). Capitalized terms not defined in this Amendment shall have the respectiv |
|
| January 2, 2020 |
SGRY / Surgery Partners, Inc. CORRESP - - SURGERY PARTNERS, INC. 310 Seven Springs Way, Suite 500 Brentwood, TN 37027 January 2, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F. Street, N.E. Washington, D.C. 20549 Re: Surgery Partners, Inc. Registration Statement on Form S-3 Filed on December 20, 2019 (File No. 333-235664) Request for Acceleration Ladies and Gentlemen: Pursua |
|
| January 2, 2020 |
SGRY / Surgery Partners, Inc. CORRESP - - ROPES & GRAY LLP 1211 AVENUE OF THE AMERICAS NEW YORK, NY 10036 WWW.ROPESGRAY.COM January 2, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F. Street, N.E. Washington, D.C. 20549 Thomas Holden T +1 415 315 2355 [email protected] Re: Surgery Partners, Inc. Registration Statement on Form S-3 Filed on December 20, 2019 (File No. |
|
| December 30, 2019 |
SGRY / Surgery Partners, Inc. CORRESP - - ROPES & GRAY LLP 1211 AVENUE OF THE AMERICAS NEW YORK, NY 10036 WWW.ROPESGRAY.COM December 30, 2019 VIA EDGAR Thomas Holden T +1 415 315 2355 [email protected] Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F. Street, N.E. Washington, D.C. 20549 Re: Surgery Partners, Inc. Registration Statement on Form S-3 Filed on December 20, 2019 (File N |
|
| December 20, 2019 |
SGRY / Surgery Partners, Inc. S-3 - - S-3 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on December 20, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 20, 2019 |
Form of Indenture (filed herewith) Exhibit 4.4 SURGERY PARTNERS, INC. and [ ], as Trustee INDENTURE Dated as of [ ], [ ] TABLE OF CONTENTS ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 1.1. DEFINITIONS 1 1.2. OTHER DEFINITIONS 5 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT 5 1.4. RULES OF CONSTRUCTION 6 ARTICLE II THE SECURITIES 6 2.1. ISSUABLE IN SERIES 6 2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES 7 2.3 |
|
| November 6, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of r |
|
| November 5, 2019 |
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2019 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2019 RESULTS BRENTWOOD, Tenn., November 5, 2019 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2019. • Revenues increased 4.5% over the prior year period to $452.0 mil |
|
| November 5, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a3q198-kearnings.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2019 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of |
|
| August 12, 2019 |
SGRY / Surgery Partners, Inc. S-8 - - S-8 As filed with the Securities and Exchange Commission on August 12, 2019 Registration No. |
|
| August 9, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regist |
|
| August 9, 2019 |
First Amendment to the Surgery Partners, Inc. 2015 Omnibus Incentive Plan. Exhibit 10.1 First Amendment to the Surgery Partners, Inc. 2015 Omnibus Incentive Plan This Amendment to the Surgery Partners, Inc. 2015 Omnibus Incentive Plan (the “Plan”) is adopted by Surgery Partners, Inc. (the “Company”), effective as of May 29, 2019. WHEREAS, the Company has established the Plan through which the Company may grant awards of stock options, stock appreciation rights, restricte |
|
| August 7, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a2q198-kearnings.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2019 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of I |
|
| August 7, 2019 |
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2019 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2019 RESULTS BRENTWOOD, Tenn., August 7, 2019 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter ended June 30, 2019. • Revenues increased 2.0% over the prior year period to $445.4 million; Adjusted Revenues |
|
| June 25, 2019 |
8-K 1 a20196258-kdepartureofange.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2019 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdic |
|
| May 31, 2019 |
8-K 1 a20198-kannualmeetingresul.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2019 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdict |
|
| May 28, 2019 |
SGRY / Surgery Partners, Inc. / Nn Group N.v. - SC 13G AMENDMENT NO. 2 Passive Investment SC 13G Amendment No. 2 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 2) Surgery Partners, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 86881A100 (CUSIP Numbe |
|
| May 28, 2019 |
IDENTITY AND THE ITEM 3 CLASSIFICATION OF THE RELEVANT SUBSIDIARIES EX-99.1 Exhibit 99.1 IDENTITY AND THE ITEM 3 CLASSIFICATION OF THE RELEVANT SUBSIDIARIES The securities being reported on by NN Group N.V. (the “Reporting Person”), as a parent holding company, are owned by NN Investment Partners B.V. and NN Investment Partners Towarzystwo Funduszy Inwestycyjnych S.A., each of which is a subsidiary of the Reporting Person and a non-U.S. institution in accordance w |
|
| May 10, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of regis |
|
| May 10, 2019 |
Exhibit 10.4 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this "Agreement") is made as of June 13, 2014, between Symbion, Inc., a Delaware corporation (the "Company"), and George M. Goodwin ("Executive"). WHEREAS, simultaneously with the execution of this Agreement, Surgery Center Holdings, LLC, a Delaware limited liability company (the "Parent"), SH Acquisition Corp. a Delaware corporation and |
|
| May 10, 2019 |
Exhibit 10.3 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "Agreement") is hereby entered into effective as of February 22. 2018 (the "Effective Date"), between Surgery Partners, Inc. (the "Company") and Angela Justice ("Executive''). 1.Employment. The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set forth |
|
| May 8, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2019 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 8, 2019 |
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2019 RESULTS Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2019 RESULTS BRENTWOOD, Tenn., May 8, 2019 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the first quarter ended March 31, 2019. • Revenues increased 1.3% over prior year period to $416.8 million • Same-facility revenues i |
|
| April 30, 2019 |
Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 30, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| April 12, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2019 Surgery Partners, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37576 47-3620923 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 12, 2019 |
Exhibit 4.1 Execution Version SURGERY CENTER HOLDINGS, INC., as Issuer the GUARANTORS party hereto from time to time and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee $430,000,000 10.000% Senior Notes due 2027 INDENTURE Dated as of April 11, 2019 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 SECTION 1.1 Definitions 1 SECTION 1.2 Other Definitions 50 SECTION 1.3 |
